Simplex Trading’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,338
Closed -$77K 8938
2025
Q4
$86.2K Buy
+17,338
New +$75.6K ﹤0.01% 5146
2025
Q3
Sell
-5,152
Closed -$14.1K 8931
2025
Q2
$11K Buy
5,152
+1,416
+38% +$4.03K ﹤0.01% 7216
2025
Q1
$9K Buy
+3,736
New +$11.6K ﹤0.01% 7135
2024
Q1
Sell
-11,560
Closed -$51.3K 8714
2023
Q4
$47K Buy
11,560
+11,075
+2,284% +$48.2K ﹤0.01% 6123
2023
Q3
$2K Sell
485
-1,572
-76% -$7.92K ﹤0.01% 8023
2023
Q2
$10K Buy
2,057
+530
+35% +$3.72K ﹤0.01% 7365
2023
Q1
$10K Buy
1,527
+1,458
+2,113% +$6.93K ﹤0.01% 7512
2022
Q4
$0 Buy
+69
New +$177 ﹤0.01% 9059
2022
Q3
Sell
-2,248
Closed -$10K 9780
2022
Q2
$10K Sell
2,248
-10,238
-82% -$69.4K ﹤0.01% 8258
2022
Q1
$94K Buy
12,486
+12,145
+3,562% +$90.4K ﹤0.01% 6237
2021
Q4
$2K Buy
+341
New +$2.68K ﹤0.01% 9943
2016
Q2
Sell
-4
Closed -$6K 5719
2016
Q1
$6K Sell
4
-3
-43% -$4.89K ﹤0.01% 3890
2015
Q4
$17K Buy
+7
New +$29.6K ﹤0.01% 2824
2015
Q3
Hold
0
5420
2015
Q2
Hold
0
5075
2015
Q1
Hold
0
4875
2014
Q4
Hold
0
4632

Other funds holding ACHV

Simplex Trading's ACHV Position: Q1 2026 in Review

Simplex Trading sold out of Achieve Life Sciences (ACHV) in Q1 2026, closing a stake of 17,338 shares — an estimated $77K sold.

Simplex Trading first reported a position in ACHV in Q4 2015 and held it in 13 quarters. The position peaked at $94K in Q1 2022. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Simplex Trading reported no remaining Achieve Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 17,338 Achieve Life Sciences shares in Q1 2026, an estimated $77K.
  • Simplex Trading first reported a position in Achieve Life Sciences in Q4 2015 and held it in 13 quarters.
  • Simplex Trading's Achieve Life Sciences position peaked at $94K in Q1 2022.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.